Returning back in 2019

Shanghai, China

Pre Conference Workshop
Tuesday, 25th September 2018

09.30 - 13.30
Guide to Utilising Humanized Mice for Your Immuno-Oncology Preclinical Research for Increased Translational Success
Workshop Leader: James Keck, Senior Director In Vivo Pharmacology, The Jackson Laboratory

In this workshop you will find:

  • Patient derived xenograft (PDX) mouse models recapitulate disease progression and respond to standard of care (SoC) and experimental therapies
  • Specialized, immunodeficient mouse models are efficiently reconstituted with functional human immune cells
  • Tumor-bearing, humanized NSG and NSG-SGM3 (Onco-Hu) mice are a new and valuable tool for Immuno-Oncology research.

James Keck, Senior Director In Vivo Pharmacology, The Jackson Laboratory